Journal
MOLECULAR IMMUNOLOGY
Volume 45, Issue 15, Pages 3902-3908Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.molimm.2008.06.023
Keywords
Inflammation; Signaling; NFAT; IRAK-1; Cardiovascular disease
Categories
Funding
- National Institute of Health
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064414] Funding Source: NIH RePORTER
Ask authors/readers for more resources
IRAK-1 is a critical modulator regulating innate immunity signaling processes. However, the physiological substrates for IRAK-I remain poorly defined. In this report, we have demonstrated that IRAK-I is a kinase responsible for the constitutive phosphorylation and inactivation of the Nuclear Factor of Activated T-cell (NFAT). Expression of IRAK-I suppressed NFAT reporter activity. Correspondingly, the levels of both nuclear NFATc1 and NFATc4 were constitutively elevated in IRAK-1(-/-) cells. Furthermore, the phosphorylation of NFATc4 at the S168PS170P site was significantly diminished in IRAK-1(-/-) cells. Mechanistically, we observed that IRAK-1 interacted with NFATc4 via the C-terminus of IRAK-1 and the N-terminal NHR region of NFATc4. IRAK-I mutants that ablated either its kinase activity or its interaction with NFATc4 failed to suppress NFAT reporter activity. The expression level of COX2, which is under the control of NFAT, was elevated in IRAK-1(-/-) cells. Functionally, ApoE(-/-)/IRAK-1(-/-) mice were protected from high-fat-diet-induced hypertension and atherosclerosis. Taken together, our findings reveal NFAT molecules as novel physiological targets for IRAK-1. (C) 2008 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available